Hospital Level (Tertiary & Quaternary) - Medicine Recommendations, Medicine Reviews and Costing Reports - 2022 - 2024

Hospital Level (Tertiary & Quaternary) - Medicine Recommendations, Medicine Reviews and Costing Reports - 2022 - 2024

The evidence-based medicine recommendations included in the Tertiary and Quaternary Essential Medicines List (EML) are reviewed through the transparent critical appraisal of global evidence, using a systematic evidence-to-decision framework. The Tertiary and Quaternary Hospital Level EML, which constitutes a list of essential medicines for approved indication, is ratified and distributed quarterly following NEMLC approval. It guides the selection, procurement and use of medicines at Tertiary and Quaternary level health establishments in the public sector in South Africa.

Medicine Review and Costing Analyses
A Medicine Review is the process whereby relevant clinical evidence on a specific medicine is gathered and analysed, with the findings presented in a Medicine Review Technical Report that is presented to the NEMLC for appraisal. A Medicine Review is conducted to determine if a medicine should be added or deleted from the EML for a specific indication.

Costing analyses compare the cost of two regiments or formulations. Aspects like costs of treatments and human resources are considered, and clearly state the assumptions made when conducting the analysis.

All the Hospital Level – Tertiary and Quaternary (TQ) Medicine Recommendations, Medicine Reviews and Costing Reports from 2022 to date have been moved to the National Health Insurance webpage on the National Department of Health website. They can be accessed on the following link: https://www.health.gov.za/nhi-hpp-edp/
Type
Reports
Topic
Medicine Recommendations
Medicine Reviews and Costing Documents
Language
English
Publisher
National Department of Health
Year
2024